Identification of Tumor Antigens and Immune Landscape in Glioblastoma for mRNA Vaccine Development

Background: Clinical benefits from standard therapies against glioblastoma (GBM) are limited in part due to the intrinsic radio- and chemo-resistance. As an essential part of tumor immunotherapy for adjunct, therapeutic tumor vaccines have been effective against multiple solid cancers, while their e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Liguo, Wang, Long, Yang, Ji’an, Hu, Ping, Zhang, Chunyu, Tong, Shi’ao, Liu, Zhennan, Tian, Daofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435740/
https://www.ncbi.nlm.nih.gov/pubmed/34527020
http://dx.doi.org/10.3389/fgene.2021.701065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435740/
https://www.ncbi.nlm.nih.gov/pubmed/34527020
http://dx.doi.org/10.3389/fgene.2021.701065

Ejemplares similares